{"id":"https://openalex.org/W2624529232","doi":"https://doi.org/10.1055/s-2006-950753","title":"Resistenzentwicklung unter Therapie mit dem Proteaseinhibitor VX-950 bei Patienten mit einer HCV Genotyp 1 Infektion","display_name":"Resistenzentwicklung unter Therapie mit dem Proteaseinhibitor VX-950 bei Patienten mit einer HCV Genotyp 1 Infektion","publication_year":2006,"publication_date":"2006-09-19","ids":{"openalex":"https://openalex.org/W2624529232","doi":"https://doi.org/10.1055/s-2006-950753","mag":"2624529232"},"language":"de","primary_location":{"id":"doi:10.1055/s-2006-950753","doi":"https://doi.org/10.1055/s-2006-950753","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2006-950753","pdf_url":null,"source":{"id":"https://openalex.org/S189922908","display_name":"Zeitschrift f\u00fcr Gastroenterologie","issn_l":"0044-2771","issn":["0044-2771","1439-7803"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zeitschrift f\u00fcr Gastroenterologie","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070817587","display_name":"Christoph Sarrazin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094678","display_name":"Universit\u00e4tsklinikum des Saarlandes","ror":"https://ror.org/00nvxt968","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094678"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C Sarrazin","raw_affiliation_strings":["Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany","institution_ids":["https://openalex.org/I4210094678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057269368","display_name":"Tara L. Kieffer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T Kieffer","raw_affiliation_strings":["Vertex Pharamceuticals, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharamceuticals, Boston, United States of America","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111554926","display_name":"Doug J. Bartels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Bartels","raw_affiliation_strings":["Vertex Pharamceuticals, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharamceuticals, Boston, United States of America","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041516206","display_name":"Brian L. Hanzelka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Hanzelka","raw_affiliation_strings":["Vertex Pharamceuticals, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharamceuticals, Boston, United States of America","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078433142","display_name":"Ute M\u00fch","orcid":"https://orcid.org/0009-0007-7114-019X","observed_orcids":["https://orcid.org/0009-0007-7114-019X"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U M\u00fch","raw_affiliation_strings":["Vertex Pharamceuticals, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharamceuticals, Boston, United States of America","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006291024","display_name":"MW Welker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094678","display_name":"Universit\u00e4tsklinikum des Saarlandes","ror":"https://ror.org/00nvxt968","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094678"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"MW Welker","raw_affiliation_strings":["Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany","institution_ids":["https://openalex.org/I4210094678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047359266","display_name":"Den\ufeffnis Wincheringer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094678","display_name":"Universit\u00e4tsklinikum des Saarlandes","ror":"https://ror.org/00nvxt968","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094678"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D Wincheringer","raw_affiliation_strings":["Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany","institution_ids":["https://openalex.org/I4210094678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101796123","display_name":"Chia\u2010Chen Lin","orcid":"https://orcid.org/0000-0003-0432-6289","observed_orcids":["https://orcid.org/0000-0003-0432-6289"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Lin","raw_affiliation_strings":["Vertex Pharamceuticals, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharamceuticals, Boston, United States of America","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017786923","display_name":"Susan Purdy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Purdy","raw_affiliation_strings":["Vertex Pharamceuticals, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharamceuticals, Boston, United States of America","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010550239","display_name":"Christine J. Weegink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"C Weegink","raw_affiliation_strings":["Academic Medical Center Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Medical Center Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070630828","display_name":"Henk W. Reesink","orcid":"https://orcid.org/0000-0002-5298-2494","observed_orcids":["https://orcid.org/0000-0002-5298-2494","https://orcid.org/0000-0002-6199-9247"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H Reesink","raw_affiliation_strings":["Academic Medical Center Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Medical Center Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045504446","display_name":"Stefan Zeuzem","orcid":"https://orcid.org/0000-0002-0845-6833","observed_orcids":["https://orcid.org/0000-0002-0845-6833"]},"institutions":[{"id":"https://openalex.org/I4210094678","display_name":"Universit\u00e4tsklinikum des Saarlandes","ror":"https://ror.org/00nvxt968","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094678"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"S Zeuzem","raw_affiliation_strings":["Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitaetsklinikum des Saarlandes, Innere Medizin II, Homburg, Germany","institution_ids":["https://openalex.org/I4210094678"]}]},{"author_position":"last","author":{"id":null,"display_name":"A Kwong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Kwong","raw_affiliation_strings":["Vertex Pharamceuticals, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharamceuticals, Boston, United States of America","institution_ids":["https://openalex.org/I61970326"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.44141454,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"44","issue":"08","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/boceprevir","display_name":"boceprevir","score":0.6690000295639038},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.8289999961853027},{"id":"https://openalex.org/keywords/ns3-4a-protease-inhibitors","display_name":"NS3/4A protease inhibitors","score":0.8759999871253967},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.7350000143051147},{"id":"https://openalex.org/keywords/resistant-mutants","display_name":"resistant mutants","score":0.4650000035762787},{"id":"https://openalex.org/keywords/hcv-quasispecies","display_name":"HCV quasispecies","score":0.8130000233650208},{"id":"https://openalex.org/keywords/viral-rebound","display_name":"viral rebound","score":0.6729999780654907},{"id":"https://openalex.org/keywords/hcv-viral-load","display_name":"HCV RNA viral load","score":0.7170000076293945},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.3479999899864197},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.4339999854564667},{"id":"https://openalex.org/keywords/hcv-rna-quantification","display_name":"HCV RNA quantification","score":0.3199999928474426},{"id":"https://openalex.org/keywords/hcv-genotyping","display_name":"HCV genotyping","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5125917792320251},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3635837733745575}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-2006-950753","doi":"https://doi.org/10.1055/s-2006-950753","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2006-950753","pdf_url":null,"source":{"id":"https://openalex.org/S189922908","display_name":"Zeitschrift f\u00fcr Gastroenterologie","issn_l":"0044-2771","issn":["0044-2771","1439-7803"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zeitschrift f\u00fcr Gastroenterologie","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2047662447","https://openalex.org/W2162384376","https://openalex.org/W2140369033","https://openalex.org/W2139677692","https://openalex.org/W1976334134","https://openalex.org/W2170919492","https://openalex.org/W1966615091","https://openalex.org/W2139507494","https://openalex.org/W106366347","https://openalex.org/W2024726373"],"abstract_inverted_index":{"Einleitung:":[0],"VX-950":[1,76,149,243,295],"ist":[2],"ein":[3,191],"oral":[4],"verf\u00fcgbarer":[5],"Inhibitor":[6],"der":[7,35,44,58,65,118,132,140,157,164,168,174,195,205,238,261],"Hepatitis":[8,48],"C":[9,49],"Virus":[10,50],"(HCV)":[11],"NS3/4A":[12],"Protease.":[13],"Unter":[14,237],"einer":[15,20,246,287,291],"Therapie":[16,100,176,239,248,293],"bei":[17,51,177,223,290],"Patienten":[18,180,225],"mit":[19,63,75,145,161,185,229,240,251,286,294],"HCV":[21,36,69,119,169,196,206,262],"Genotyp":[22],"1":[23],"Infektion":[24],"kommt":[25],"es":[26],"innerhalb":[27,245],"von":[28,60,71,113,212],"14":[29,78],"Tagen":[30],"zu":[31,274],"einem":[32,162,252],"mittleren":[33],"Abfall":[34,194,204,260],"RNA":[37,70,170,197,263],"Konzentration":[38,171,198,264],"um":[39,271],"4":[40,138],"log":[41],"Stufen.":[42],"Aufgrund":[43],"hohen":[45,186],"Replikationseffektivit\u00e4t":[46],"des":[47,188],"gleichzeitig":[52],"niedriger":[53],"Replikationsgenauigkeit":[54],"besteht":[55],"die":[56,74],"Gefahr":[57],"Selektion":[59],"resistenten":[61,158],"Mutanten":[62,134,159,231,250,279],"Wirkungsverlust":[64,254],"Proteaseinhibitortherapie.":[66],"Methoden:":[67],"Die":[68,155],"28":[72],"Patienten,":[73],"\u00fcber":[77,208],"Tage":[79],"behandelt":[80],"wurden":[81,143],"(Placebo":[82],"oder":[83],"3\u00d7450mg,":[84],"3\u00d7750mg,":[85],"2\u00d71250mg":[86],"pro":[87,121],"Tag),":[88],"wurde":[89,126],"aus":[90],"Serumproben":[91],"vor,":[92],"unter,":[93],"am":[94],"Ende":[95],"und":[96,102,111,123,166,190,265],"im":[97,114,281],"Verlauf":[98],"nach":[99,219],"isoliert":[101],"das":[103,129],"NS3":[104,141,227],"Proteasegen":[105],"amplifiziert.":[106],"Anschlie\u00dfend":[107],"erfolgte":[108],"eine":[109,266,272],"Klonierung":[110],"Sequenzierung":[112],"Mittel":[115],"80":[116],"Isolaten":[117],"Quasispezies":[120],"Zeitpunkt":[122],"Patient.":[124],"Zus\u00e4tzlich":[125],"in":[127],"vitro":[128],"Resistenzniveau":[130,147],"(IC50)":[131],"nachgewiesenen":[133],"bestimmt.":[135],"Ergebnisse:":[136],"An":[137],"Aminos\u00e4urepositionen":[139],"Protease":[142],"Mutationen":[144],"unterschiedlichem":[146],"gegen\u00fcber":[148],"nachgewiesen":[150],"(V36,":[151],"T54,":[152],"R155,":[153],"A156).":[154],"Entwicklung":[156],"war":[160],"Durchbruch":[163],"Replikation":[165],"Wideranstieg":[167],"noch":[172],"w\u00e4hrend":[173],"14-t\u00e4gigen":[175],"den":[178,209],"betroffenen":[179],"verbunden.":[181],"Eine":[182],"optimale":[183,267],"Dosierung":[184,268],"Plasmaspiegeln":[187],"Proteaseinhibitors":[189],"rascher":[192],"initialer":[193,259],"waren":[199],"entscheidend":[200],"f\u00fcr":[201],"einen":[202],"kontinuierlichen":[203],"Viruslast":[207],"gesamten":[210],"Therapiezeitraum":[211],"2":[213],"Wochen.":[214],"Im":[215],"Langzeitverlauf":[216,282],"3\u20137":[217],"Monate":[218],"Therapieende":[220],"fanden":[221],"sich":[222],"12":[224],"weiterhin":[226],"Varianten":[228],"niedrig-resistenten":[230],"(44%":[232],"V36,":[233],"30%":[234],"R155).":[235],"Schlussfolgerung:":[236],"dem":[241],"Proteaseinhibitor":[242],"k\u00f6nnen":[244],"2-w\u00f6chigen":[247],"resistente":[249,278],"entsprechenden":[253],"selektioniert":[255],"werden.":[256],"Ein":[257],"steiler":[258],"sind":[269],"entscheidend,":[270],"Resistenzentwicklung":[273],"vermeiden.":[275],"Einmal":[276],"selektionierte":[277],"bleiben":[280],"erhalten.":[283],"Dies":[284],"d\u00fcrfte":[285],"verminderten":[288],"Wirkungseffektivit\u00e4t":[289],"erneuten":[292],"einhergehen.":[296]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-06-15T00:00:00"}